{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05201469",
            "orgStudyIdInfo": {
                "id": "DAIT ITN091AI"
            },
            "organization": {
                "fullName": "National Institute of Allergy and Infectious Diseases (NIAID)",
                "class": "NIH"
            },
            "briefTitle": "VIBRANT: VIB4920 for Active Lupus Nephritis",
            "officialTitle": "A Mid-phasea Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Kidney Involvement in Lupus (ITN091AI)",
            "acronym": "VIBRANT",
            "therapeuticArea": [
                "Immunology and Rheumatology"
            ],
            "study": "vibrant-for-active-lupus-nephritis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-01-07",
            "studyFirstSubmitQcDate": "2022-01-07",
            "studyFirstPostDateStruct": {
                "date": "2022-01-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "National Institute of Allergy and Infectious Diseases (NIAID)",
                "class": "NIH"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in patients with active lupus nephritis (LN).",
            "detailedDescription": "Seventy-four eligible patients with active lupus nephritis (LN) will be randomized to receive VIB4920 1500 mg or placebo intravenously at Weeks 0, 2, 4, 8, 12, 16, 20, and 24. Participants will also receive methylprednisolone 1000 mg at Week 0 and will begin MMF 2-3 g per day and prednisone 25 mg per day, tapered to \u2264 5 mg per day from Week 8. The primary endpoint will be assessed at Week 36, and patients followed until Week 60."
        },
        "conditionsModule": {
            "conditions": [
                "Lupus Nephritis"
            ],
            "keywords": [
                "Lupus Nephritis",
                "Mycophenolate mofetil",
                "VIB4920"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 74,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "VIB4920",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive VIB4920 1500 mg intravenously at Weeks 0, 2, 4, 8, 12, 16, 20, and 24.\n\nParticipants will also receive methylprednisolone 1000 mg at Week 0 and will begin MMF 2-3 g per day and prednisone 25 mg per day, tapered to \u2264 5 mg per day from Week 8.",
                    "interventionNames": [
                        "Drug: VIB4920"
                    ]
                },
                {
                    "label": "VIB4920 Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive VIB4920 placebo intravenously at Weeks 0, 2, 4, 8, 12, 16, 20, and 24.\n\nParticipants will also receive methylprednisolone 1000 mg at Week 0 and will begin MMF 2-3 g per day and prednisone 25 mg per day, tapered to \u2264 5 mg per day from Week 8.",
                    "interventionNames": [
                        "Drug: Placebo for VIB4920"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VIB4920",
                    "description": "Participants will receive 1500 mg of VIB4920 at Weeks 0, 2, 4, 8, 12, 16, 20, and 24 while continuing on MMF and prednisone",
                    "armGroupLabels": [
                        "VIB4920"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo for VIB4920",
                    "description": "Participants will receive placebo for VIB4920 at Weeks 0, 2, 4, 8, 12, 16, 20, and 24 while continuing on MMF and prednisone",
                    "armGroupLabels": [
                        "VIB4920 Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of participants achieving a complete renal response at week 36",
                    "description": "Complete renal response is defined as all of the following:\n\n1. Urine protein-to-creatinine ratio (UPCR) \\<= 0.5, based on a 24-hour urine collection\n2. Estimated glomerular filtration rate (eGFR) \\>= 120 ml/min/1.73 m\\^2 or, if \\< 120 ml/min/1.73 m\\^2, then \\>= 80 percent of the eGFR at baseline\n3. Prednisone \\<= 5 mg/day from Week 8, according to the prednisone dosing restrictions",
                    "timeFrame": "Week 36"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of participants who achieve a complete renal response",
                    "description": "Complete renal response is defined as all of the following:\n\n1. Urine protein-to-creatinine ratio (UPCR) \\<= 0.5, based on a 24-hour urine collection\n2. Estimated glomerular filtration rate (eGFR) \\>= 120 ml/min/1.73 m\\^2 or, if \\< 120 ml/min/1.73 m\\^2, then \\> 80 percent of the eGFR at Week 0\n3. Prednisone tapered to \\<= 5 mg/day by Week 8, and adherence to the prednisone dosing restrictions",
                    "timeFrame": "Weeks 12, 24, 48, and 60"
                },
                {
                    "measure": "Proportion of participants who achieve an overall renal response",
                    "description": "Overall renal response is defined as all of the following:\n\n1. \\>= 50 percent improvement in the urine protein-to-creatinine ratio (UPCR) compared to baseline, based on a 24-hour urine collection\n2. Estimated glomerular filtration rate (eGFR) \\>= 120 ml/min/1.73 m\\^2, or if \\< 120 ml/min/1.73 m\\^2, then \\> 80 percent of the eGFR at baseline, and\n3. Prednisone \\<= 5 mg/day from Week 8, according to the prednisone dosing restrictions",
                    "timeFrame": "Weeks 12, 24, 36, 48 and 60"
                },
                {
                    "measure": "Proportion of participants who achieve a BLISS-LN primary efficacy renal response (PERR)",
                    "description": "BLISS-LN primary efficacy renal response (PERR) defined as all of the following:\n\n1. UPCR \u2264 0.7, and\n2. eGFR \u2265 60 ml/min/1.73m2, or if \\< 60 ml/min/1.73m2, then \u2265 80% of the eGFR at baseline, and\n3. no receipt of a prohibited immunosuppressive or immunomodulatory medication",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Urine Protein-to-Creatinine Ratio (UPCR)",
                    "description": "Based on 24-hour urine collection",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Anti-dsDNA antibodies",
                    "description": "The change in the proportion of participants who had a negative anti-dsDNA test will be summarized by arm, and will be analyzed using an exact conditional logistic regression model",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Change in proportion of participants with lower C3 levels after treatment initiation",
                    "description": "The change in the proportion of participants who were hypocomplementemic for C3 and C4 after initiation of VIB4920 or placebo will be summarized by arm, and analyzed using an exact conditional logistic regression model",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Change in proportion of participants with lower C4 levels after treatment initiation",
                    "description": "The change in the proportion of participants who were hypocomplementemic for C3 and C4 after initiation of VIB4920 or placebo will be summarized by arm, and analyzed using an exact conditional logistic regression model",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)",
                    "description": "The change in SLEDAI-2K scores after initiation of VIB4920 or placebo will be summarized by arm, and analyzed using an analysis of covariance (ANCOVA) model",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus (SLICC/ACR-DI)",
                    "description": "The change in SLICC/ACR-DI scores after initiation of VIB4920 or placebo will be summarized by arm, and analyzed using an ANCOVA model",
                    "timeFrame": "Weeks 24 and 60"
                },
                {
                    "measure": "Proportion of participants who experience renal treatment failures",
                    "description": "Renal treatment failure is defined as any one of the following:\n\n1. Worsening proteinuria, defined as both of the following:\n\n   1. Urine protein-to-creatinine ratio (UPCR) \\> 1.0\n   2. \\>= 50 percent increase in UPCR compared to the lowest previous value\n2. Progressive deterioration in renal function, defined as both of the following:\n\n   1. Serum creatinine \\>1.5\n   2. \\>= 50 percent increase in serum creatinine compared to the lowest previous value\n3. Nephritis that worsens or fails to sufficiently improve, according to the judgment of the investigator\n4. Receipt of a prohibited immunosuppressive medication, including but not limited to cyclophosphamide, azathioprine, solumedrol, rituximab, belimumab, and calcineurin inhibitors",
                    "timeFrame": "Week 0 to Week 60"
                },
                {
                    "measure": "Number of participants who experience at least one serious adverse event",
                    "description": "The number of participants who experienced at least one SAE and the number of participants who experienced at least one AESI will be analyzed using a Fisher's exact test.",
                    "timeFrame": "Week 0 to Week 60"
                },
                {
                    "measure": "Number of participants who experience at least one adverse Events of Special Interest",
                    "description": "Adverse Events of Special Interests include:\n\n1. Anaphylaxis\n2. Grade 3 or greater infusion reaction\n3. Grade 3 or greater hypersensitivity reaction\n4. Grade 3 or greater infection\n5. Thromboembolic event",
                    "timeFrame": "Week 0 to Week 60"
                },
                {
                    "measure": "Change in Serum IgM over study participation",
                    "description": "Serum IgM levels will be analyzed using a longitudinal mixed effects model with the test results at the time points as the dependent variable",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                },
                {
                    "measure": "Change in Serum IgG over study participation",
                    "description": "Serum IgG levels will be analyzed using a longitudinal mixed effects model with the test results at the time points as the dependent variable",
                    "timeFrame": "Weeks 12, 24, 36, 48, and 60"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nIndividuals who meet all of the following criteria are eligible for enrollment as study participants:\n\n1. Age 18 years or older.\n2. Classification of Systemic Lupus Erythematosus (SLE) by any of the following criteria: the 1997 update of the 1982 American College of Rheumatology (ACR) criteria, the 2012 Systemic Lupus International Collaborating Clinics (SLICC) criteria, or the 2019 European League Against Rheumatism (EULAR)/ACR criteria.\n3. UPCR \u2265 1.0 based on a 24-hour urine collection at Visit -1.\n4. Renal biopsy within 24 weeks prior to Visit -1 of ISN/RPS LN with both of the following:\n\n   1. Class III, Class IV, or Class V in combination with Class III or IV, and\n   2. Modified NIH Activity Index \u2265 1.\n\nExclusion Criteria:\n\nIndividuals who meet any of these criteria are not eligible for enrollment as study participants:\n\n1. Inability or unwillingness to give written informed consent or comply with study protocol.\n2. Contraindication to treatment with MMF or mycophenolate sodium; or treatment with MMF or mycophenolate sodium is inappropriate in the opinion of the investigator.\n3. Treatment with a biologic agent, except belimumab, or investigational agent within 90 days or 5 half-lives prior to Visit 0, whichever is longer. Agents authorized by the FDA for prevention or treatment of COVID-19 are not considered investigational and are not exclusionary.\n4. Rituximab or other B cell depleting agent within 6 months prior to Visit 0.\n5. Prior treatment with VIB4920.\n6. Receipt of a live attenuated vaccine within 4 weeks prior to Visit 0.\n7. Comorbidities requiring treatment with systemic corticosteroids, including those that have required 3 or more courses of systemic corticosteroids within 12 months prior to Visit 0.\n8. Current malignancy or history of malignancy, except for adequately treated basal cell carcinoma, squamous cell carcinoma, or cervical carcinoma in situ \\> 12 months prior to Visit 0.\n9. End stage renal disease, defined as eGFR \\< 20 ml/min/1.73m2.\n10. History of transplantation.\n11. The following risks for thromboembolic events:\n\n    1. Recent or recurrent deep venous thrombosis or arterial thromboembolism.\n    2. Immobilization or major surgery within 12 weeks prior to Visit 0.\n    3. History of congenital or inherited deficiency of antithrombin III, protein S, or protein C.\n    4. History of anti-phospholipid syndrome, according to the 2006 Sapporo classification criteria.\n12. History of a severe allergy or hypersensitivity reaction to any component of the VIB4920 formulation.\n13. Any one of the following laboratory abnormalities:\n\n    1. Peripheral B cell count \\< 5/\u03bcl.\n    2. Neutropenia (absolute neutrophil count \\< 1000/mm3).\n    3. Anemia (hemoglobin \\< 8 g/dL).\n    4. Thrombocytopenia (platelets \\< 50,000/mm3).\n    5. Aspartate aminiotransferase or alanine aminotransferase \u2265 2x upper limit of normal.\n14. Evidence of current or prior tuberculosis infection, including any of the following:\n\n    1. Positive QuantiFERON-TB Gold or TB Gold Plus test.\n    2. Positive T-SPOT.TB test.\n    3. Positive purified protein derivation (PPD) tuberculin test, defined as \\> 5mm induration.\n15. Human immunodeficiency virus (HIV) infection.\n16. Current or past hepatitis B (HBV) infection.\n17. Current or past hepatitis C virus (HCV) infection, except adequately treated HCV with documented sustained virologic response.\n18. Active bacterial, viral, fungal, or opportunistic infection.\n19. History of significant, recurrent, or chronic infection that may pose additional risks from participating in the study, in the opinion of the investigator.\n20. History of severe psychiatric condition that would interfere with the participant's ability to comply with the study protocol, in the opinion of the investigator.\n21. Current substance abuse, or history of substance abuse within 12 months of Visit 0.\n22. Lack of peripheral venous access.\n23. Pregnancy.\n24. Breastfeeding.\n25. Unwillingness to use a medically acceptable form of contraception for the duration of the study if female of child-bearing potential or if male with a partner of childbearing potential.\n26. Past or current medical problems or findings from physical examination or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Maria Dall'Era, M.D.",
                    "affiliation": "University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center",
                    "role": "STUDY_CHAIR"
                },
                {
                    "name": "Betty Diamond, M.D.",
                    "affiliation": "Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases",
                    "role": "STUDY_CHAIR"
                },
                {
                    "name": "David Wofsy, M.D.",
                    "affiliation": "University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Erica Brodie",
                            "role": "CONTACT",
                            "phone": "858-246-2386",
                            "email": "ebrodie@health.ucsd.edu"
                        },
                        {
                            "name": "Amina Arshad",
                            "role": "CONTACT",
                            "phone": "858-246-2389",
                            "email": "aiarshad@health.ucsd.edu"
                        },
                        {
                            "name": "Kenneth Kalunian",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "UCLA Medical Center: Division of Rheumatology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Belen Ramirez",
                            "role": "CONTACT",
                            "phone": "310-825-2598",
                            "email": "BelenRamirez@mednet.ucla.edu"
                        },
                        {
                            "name": "Lori Sahakian",
                            "role": "CONTACT",
                            "phone": "310-794-9236",
                            "email": "Lsahakian@mednet.ucla.edu"
                        },
                        {
                            "name": "Maureen McMahon",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California, Irvine School of Medicine Division of Rheumatology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bryan Robles",
                            "role": "CONTACT",
                            "email": "bsrobles@hs.uci.edu"
                        },
                        {
                            "name": "Walid Roshan",
                            "role": "CONTACT",
                            "email": "ahmadwar@hs.uci.edu"
                        },
                        {
                            "name": "Desai Sheetal",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lidia Espino",
                            "role": "CONTACT",
                            "phone": "415-502-5108",
                            "email": "Lidia.Espino@ucsf.edu"
                        },
                        {
                            "name": "Olivia Rosenstein",
                            "role": "CONTACT",
                            "phone": "415-502-1886",
                            "email": "olivia.rosenstein@ucsf.edu"
                        },
                        {
                            "name": "Maria Dall'Era",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "University of Colorado School of Medicine: Division of Rheumatology",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Wagner",
                            "role": "CONTACT",
                            "phone": "303-724-7790",
                            "email": "elizabeth.c.wagner@cuanschutz.edu"
                        },
                        {
                            "name": "Jennyleigh Santa Rosa",
                            "role": "CONTACT",
                            "email": "Jennyleigh.santarosa@cuanschutz.edu"
                        },
                        {
                            "name": "Amber Podoll",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Yale University School of Medicine: Section of Rheumatology",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06519",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julie Heffernan",
                            "role": "CONTACT",
                            "phone": "203-785-6631",
                            "email": "julie.heffernan@yale.edu"
                        },
                        {
                            "name": "Fotios Koumpouras",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "University of Miami Miller School of Medicine: Nephrology & Hypertension Division",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carlos Bidot",
                            "role": "CONTACT",
                            "phone": "305-243-8793",
                            "email": "cbidot2@med.miami.edu"
                        },
                        {
                            "name": "Miguel Bandes",
                            "role": "CONTACT",
                            "email": "mab816@med.miami.edu"
                        },
                        {
                            "name": "Gabriel Contreras",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Emory University School of Medicine: Division of Rheumatology",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30307",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John Varghese",
                            "role": "CONTACT",
                            "phone": "404-727-2886",
                            "email": "john.varghese@emory.edu"
                        },
                        {
                            "name": "Sabeena Usman",
                            "role": "CONTACT",
                            "email": "sabeena.usman@emory.edu"
                        },
                        {
                            "name": "Arezou Khosroshahi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "University of Chicago, Department of Medicine: Rheumatology",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Gonzalez",
                            "role": "CONTACT",
                            "phone": "773-702-1229",
                            "email": "sarah.gonzalez@bsd.uchicago"
                        },
                        {
                            "name": "Yusra Irshad",
                            "role": "CONTACT",
                            "phone": "773-702-5119",
                            "email": "yusra.irshad@bsd.uchicago.edu"
                        },
                        {
                            "name": "Kichul Ko",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Washington University School of Medicine in St. Louis: Division of Nephrology",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Audrey Stratemeyer",
                            "role": "CONTACT",
                            "phone": "314-362-8749",
                            "email": "audreys@wustl.edu"
                        },
                        {
                            "name": "Brittany Zwijack",
                            "role": "CONTACT",
                            "phone": "314-747-8251",
                            "email": "bzwijack@wustl.edu"
                        },
                        {
                            "name": "Tingting Li",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases",
                    "status": "RECRUITING",
                    "city": "Manhasset",
                    "state": "New York",
                    "zip": "11030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sanita Kandasami",
                            "role": "CONTACT",
                            "phone": "516-562-2401",
                            "email": "skandasami@northwell.edu"
                        },
                        {
                            "name": "Cynthia Aranow, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79788,
                        "lon": -73.69957
                    }
                },
                {
                    "facility": "Hospital for Special Surgery, New York: Division of Rheumatology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emily Wu",
                            "role": "CONTACT",
                            "phone": "212-774-2967",
                            "email": "WuE@HSS.edu"
                        },
                        {
                            "name": "Haley Slosberg",
                            "role": "CONTACT",
                            "email": "slosbergh@hss.edu"
                        },
                        {
                            "name": "Kirou Kyriakos",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Columbia University Medical Center: Department of Medicine, Division of Rheumatology",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sean Inzerillo",
                            "role": "CONTACT",
                            "phone": "212-342-9051",
                            "email": "si2404@cumc.columbia.edu"
                        },
                        {
                            "name": "Maya Souvignier",
                            "role": "CONTACT",
                            "email": "mls2356@cumc.columbia.edu"
                        },
                        {
                            "name": "Anca Askanase",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Ohio State University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Laci Roberts",
                            "role": "CONTACT",
                            "phone": "614-685-5323",
                            "email": "laci.roberts@osumc.edu"
                        },
                        {
                            "name": "Alexander McDaniels",
                            "role": "CONTACT",
                            "phone": "614 -293-9904",
                            "email": "alexander.mcdaniels@osumc.edu"
                        },
                        {
                            "name": "Isabelle Ayoub",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Penn State Health Milton S. Hershey Medical Center: Division of Rheumatology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Hershey",
                    "state": "Pennsylvania",
                    "zip": "17033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Peri Newman",
                            "role": "CONTACT",
                            "phone": "717-531-4921",
                            "email": "pnewman@pennstatehealth.psu.edu"
                        },
                        {
                            "name": "Jamie Carter",
                            "role": "CONTACT",
                            "phone": "717-531-4921",
                            "email": "jcarter3@pennstatehealth.psu.edu"
                        },
                        {
                            "name": "Nancy Olsen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.28592,
                        "lon": -76.65025
                    }
                },
                {
                    "facility": "Temple University, Lewis Katz School of Medicine, Department of Medicine: Nephrology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19140",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julia Aruta",
                            "role": "CONTACT",
                            "email": "julia.aruta@temple.edu"
                        },
                        {
                            "name": "Zoe Pfeffer",
                            "role": "CONTACT",
                            "phone": "267-242-2902",
                            "email": "zoe.pfeffer@tuhs.temple.edu"
                        },
                        {
                            "name": "Iris Lee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "University of South Carolina",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephanie Dezzutti",
                            "role": "CONTACT",
                            "phone": "843-792-8997",
                            "email": "brays@musc.edu"
                        },
                        {
                            "name": "Lori Ann Ueberroth",
                            "role": "CONTACT",
                            "phone": "843-792-1964",
                            "email": "ueberro@musc.edu"
                        },
                        {
                            "name": "Diane Kamen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Immune Tolerance Network (ITN)",
                    "url": "https://www.immunetolerance.org/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical mechanistic data from NIAID/DAIT-funded grants and contracts",
            "timeFrame": "Within 24 months after database lock for the trial",
            "accessCriteria": "Open Access",
            "url": "http://www.immport.org/home"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009393",
                    "term": "Nephritis"
                },
                {
                    "id": "D000008181",
                    "term": "Lupus Nephritis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000005921",
                    "term": "Glomerulonephritis"
                },
                {
                    "id": "D000008180",
                    "term": "Lupus Erythematosus, Systemic"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12338",
                    "name": "Nephritis",
                    "asFound": "Nephritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11178",
                    "name": "Lupus Nephritis",
                    "asFound": "Lupus Nephritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9031",
                    "name": "Glomerulonephritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M11177",
                    "name": "Lupus Erythematosus, Systemic",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3523",
                    "name": "Lupus Nephritis",
                    "asFound": "Lupus Nephritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2525",
                    "name": "Glomerulonephritis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M14121",
                    "name": "Prednisone",
                    "relevance": "LOW"
                },
                {
                    "id": "M11749",
                    "name": "Methylprednisolone",
                    "relevance": "LOW"
                },
                {
                    "id": "M1833",
                    "name": "Methylprednisolone Acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M11750",
                    "name": "Methylprednisolone Hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M14120",
                    "name": "Prednisolone",
                    "relevance": "LOW"
                },
                {
                    "id": "M229449",
                    "name": "Prednisolone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M211887",
                    "name": "Prednisolone hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M248881",
                    "name": "Prednisolone phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M12128",
                    "name": "Mycophenolic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "NeuroAg",
                    "name": "Neuroprotective Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}